Skip to content

A comparative study of microRNA expression levels in mild cognitive impairment patients with normal and impaired olfactory function

A comparative study of microRNA expression levels in mild cognitive impairment patients with normal and impaired olfactory function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082829
Enrollment
Unknown
Registered
2024-04-09
Start date
2024-04-09
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment

Interventions

Mild cognitive impairment group with normal sense of smell:N/A
Mild cognitive impairment group with olfactory impairment:N/A

Sponsors

China Agricultural University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: Greater than 55 years of age, regardless of gender; patients with mild cognitive impairment confirmed by a neurologist using the MMSE/MoCA scale for diagnosis; olfactory function tests using the olfactory pen method, with scores lower than 10 being considered as olfactory impairment; and understanding of and voluntarily participating in this trial and signing an informed consent form.

Exclusion criteria

Exclusion criteria: Presence of intracranial infections, hydrocephalus, and cerebrovascular disease; exclusion of patients with mild cognitive impairment with any history of stroke, epilepsy, encephalitis, traumatic brain injury, malignancy, cardiac event, or serious mental illness; acute respiratory infections within 3 weeks or colds within 2 weeks; chronic rhinitis, sinusitis, and allergic rhinitis; prolonged or heavy exposure to volatile substances such as insecticides, herbicides, metal dusts, acid fumes, industrial solvents, cleaning products, or sawdust; smoking or drug use; patients with end-stage renal disease; other neuropsychiatric disorders affecting olfactory function, such as depression, anxiety, Parkinson's, and multiple sclerosis.

Design outcomes

Primary

MeasureTime frame
cognitive function;olfactory function;

Secondary

MeasureTime frame
microRNA;

Countries

China

Contacts

Public ContactXiaoyu Wang

China Agricultural University

xy.wang@cau.edu.cn+86 185 1107 6649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026